CIS bio outperforms ORIS with turnover up 14%
This article was originally published in Clinica
Turnover at French diagnostics manufacturer, CIS bio international rose 14% to top a billion francs in 1995. The growth was attributable mainly to the takeover of Behring's radiodiagnostic business. Sales outside France increased 27% in 1995 to represent two-thirds of the company's total sales.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.